---
pmid: '28335020'
title: ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar
  granule neuron loss.
authors:
- Anttonen AK
- Laari A
- Kousi M
- Yang YJ
- Jääskeläinen T
- Somer M
- Siintola E
- Jakkula E
- Muona M
- Tegelberg S
- Lönnqvist T
- Pihko H
- Valanne L
- Paetau A
- Lun MP
- Hästbacka J
- Kopra O
- Joensuu T
- Katsanis N
- Lehtinen MK
- Palvimo JJ
- Lehesjoki AE
journal: Brain
year: '2017'
full_text_available: false
doi: 10.1093/brain/awx040
---

# ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss.
**Authors:** Anttonen AK, Laari A, Kousi M, Yang YJ, Jääskeläinen T, Somer M, Siintola E, Jakkula E, Muona M, Tegelberg S, Lönnqvist T, Pihko H, Valanne L, Paetau A, Lun MP, Hästbacka J, Kopra O, Joensuu T, Katsanis N, Lehtinen MK, Palvimo JJ, Lehesjoki AE
**Journal:** Brain (2017)
**DOI:** [10.1093/brain/awx040](https://doi.org/10.1093/brain/awx040)

## Abstract

1. Brain. 2017 May 1;140(5):1267-1279. doi: 10.1093/brain/awx040.

ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar 
granule neuron loss.

Anttonen AK(1)(2)(3)(4), Laari A(1)(2)(3), Kousi M(5), Yang YJ(6)(7)(8), 
Jääskeläinen T(9)(10), Somer M(11), Siintola E(1)(2), Jakkula E(7), Muona 
M(1)(2)(3)(7), Tegelberg S(1)(2)(3), Lönnqvist T(8), Pihko H(8), Valanne L(12), 
Paetau A(13), Lun MP(14)(15), Hästbacka J(1)(16), Kopra O(1)(2)(3), Joensuu 
T(1)(2)(3), Katsanis N(5), Lehtinen MK(14), Palvimo JJ(9), Lehesjoki 
AE(1)(2)(3).

Author information:
(1)The Folkhälsan Institute of Genetics, Haartmaninkatu 8, 00290 Helsinki, 
Finland.
(2)Neuroscience Center, University of Helsinki, Viikinkaari 4, 00790 Helsinki, 
Finland.
(3)Research Programs Unit, Molecular Neurology, University of Helsinki, 
Haartmaninkatu 8, 00290 Helsinki, Finland.
(4)Medical and Clinical Genetics, University of Helsinki and Helsinki University 
Hospital, Haartmaninkatu 8, 00290 Helsinki, Finland.
(5)Center for Human Disease Modeling, Duke University Medical Center, Carmichael 
Building, 300 North Duke Street, Suite 48-118, Durham, NC 27701, USA.
(6)Division of Genetics, Howard Hughes Medical Institute.
(7)Institute for Molecular Medicine Finland, University of Helsinki, 
Haartmaninkatu 8, 00290 Helsinki, Finland.
(8)Department of Pediatric Neurology, Children's Hospital, University of 
Helsinki and Helsinki University Hospital, Lastenlinnantie 2, 00290 Helsinki, 
Finland.
(9)Institute of Biomedicine, University of Eastern Finland, Yliopistonranta 1, 
70210 Kuopio, Finland.
(10)Institute of Dentistry, University of Eastern Finland, Yliopistonranta 1, 
70210 Kuopio, Finland.
(11)The Norio Centre, The Rinnekoti Foundation, Kornetintie 8, 00380 Helsinki, 
Finland.
(12)Department of Radiology, HUS Medical Imaging Center, Haartmaninkatu 4, 00290 
Helsinki, Finland.
(13)Department of Pathology, Helsinki University Hospital, Haartmaninkatu 3, 
00290 Helsinki, Finland.
(14)Department of Pathology, Boston Children's Hospital, BCH 3108, 300 Longwood 
Ave., Boston, MA 02115, USA.
(15)Department of Pathology and Laboratory Medicine, Boston University School of 
Medicine, 670 Albany Street, Boston, MA 02118, USA.
(16)Department of Pediatrics, Children's Hospital, University of Helsinki and 
Helsinki University Hospital, Stenbäckinkatu 11, 00290 Helsinki, Finland.

Comment in
    Brain. 2017 Aug 1;140(8):e49. doi: 10.1093/brain/awx155.
    Brain. 2017 Aug 1;140(8):e50. doi: 10.1093/brain/awx157.

Progressive encephalopathy with oedema, hypsarrhythmia, and optic atrophy (PEHO) 
syndrome is an early childhood onset, severe autosomal recessive encephalopathy 
characterized by extreme cerebellar atrophy due to almost total granule neuron 
loss. By combining homozygosity mapping in Finnish families with Sanger 
sequencing of positional candidate genes and with exome sequencing a homozygous 
missense substitution of leucine for serine at codon 31 in ZNHIT3 was identified 
as the primary cause of PEHO syndrome. ZNHIT3 encodes a nuclear zinc finger 
protein previously implicated in transcriptional regulation and in small 
nucleolar ribonucleoprotein particle assembly and thus possibly to pre-ribosomal 
RNA processing. The identified mutation affects a highly conserved amino acid 
residue in the zinc finger domain of ZNHIT3. Both knockdown and genome editing 
of znhit3 in zebrafish embryos recapitulate the patients' cerebellar defects, 
microcephaly and oedema. These phenotypes are rescued by wild-type, but not 
mutant human ZNHIT3 mRNA, suggesting that the patient missense substitution 
causes disease through a loss-of-function mechanism. Transfection of cell lines 
with ZNHIT3 expression vectors showed that the PEHO syndrome mutant protein is 
unstable. Immunohistochemical analysis of mouse cerebellar tissue demonstrated 
ZNHIT3 to be expressed in proliferating granule cell precursors, in 
proliferating and post-mitotic granule cells, and in Purkinje cells. Knockdown 
of Znhit3 in cultured mouse granule neurons and ex vivo cerebellar slices 
indicate that ZNHIT3 is indispensable for granule neuron survival and migration, 
consistent with the zebrafish findings and patient neuropathology. These results 
suggest that loss-of-function of a nuclear regulator protein underlies PEHO 
syndrome and imply that establishment of its spatiotemporal interaction targets 
will be the basis for developing therapeutic approaches and for improved 
understanding of cerebellar development.

© The Author (2017). Published by Oxford University Press on behalf of the 
Guarantors of Brain. All rights reserved. For Permissions, please email: 
journals.permissions@oup.com.

DOI: 10.1093/brain/awx040
PMID: 28335020 [Indexed for MEDLINE]
